You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 7, 12 APR 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigations
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Weight Loss Intervention in Phase 1 of the Trials of Hypertension Prevention

Victor J. Stevens, PhD; Sheila A. Corrigan, PhD; Eva Obarzanek, PhD; Edmund Bernauer, PhD; Nancy R. Cook, PhD; Patricia Hebert, PhD; Mildred Mattfeldt-Beman, PhD, RD; Albert Oberman, MD; Carolyn Sugars, MS, RD; Arlene Taylor Dalcin, MS, RD; Paul K. Whelton, MD; TOHP Collaborative Research Group

Arch Intern Med. 1993;153(7):849-858.


Abstract

Background
Phase 1 of the Trials of Hypertension Prevention was a collaborative, randomized controlled clinical trial designed to determine the feasibility and efficacy of selected nonpharmacologic interventions in reducing or preventing an increase in diastolic blood pressure.

Methods
Participants aged 30 to 54 years who had a high-normal diastolic blood pressure (80 to 89 mm Hg), and were between 115% and 165% of their desirable body weight, were randomly assigned to either an 18-month weight loss intervention (n=308) or a usual-care control condition (N=256). Intervention consisted of 14 weekly group meetings followed by monthly maintenance sessions. Intervention participants received training in behavioral self-management technique and were asked to make life-style changes aimed at achieving a moderate reduction in energy intake and an increase in physical activity.

Results
The average weight losses in the intervention group at 6, 12, and 18 months of follow-up were 6.5, 5.6, and 4.7 kg for men and 3.7, 2.7, and 1.6 kg for women. The mean (±SE) change in diastolic blood pressure for intervention participants compared with controls at termination was —2.8±0.6 mm Hg for men and —1.1 ±0.9 mm Hg for women. For systolic blood pressure, the corresponding change was —3.1±0.7 mm Hg for men and —2.0±1.3 mm Hg for women. Blood pressure reductions were greater for those who lost larger amounts of weight. Sex-related differences in blood pressure response were largely due to the smaller amount of weight lost by women, and sex differences in weight loss could be accounted for by differences in baseline body weight.

Conclusions
During an 18-month follow-up period, this weight reduction program was shown to be an effective nonpharmacologic intervention for reducing blood pressure in overweight adults with high-normal blood pressure.

(Arch Intern Med. 1993;153:849-858)



Author Affiliations

From the Kaiser Permanente Center for Health Research, Portland, Ore (Dr Stevens); University of Mississippi Medical Center, Jackson (Dr Corrigan); National Heart, Lung, and Blood Institute, Bethesda, Md (Dr Obarzanek); University of California at Davis, Sacramento (Dr Bernauer and Ms Sugars); Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (Drs Cook and Hebert); St Louis (Mo) University School of Medicine (Dr Mattfeldt-Beman); University of Alabama, Birmingham (Dr Oberman); and Johns Hopkins University School of Hygiene and Public Health and School of Medicine, Baltimore, Md (Ms Dalcin and Dr Whelton).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Authors/Task Force Members: et al.
Eur Heart J 2007;0:ehm236v1-75.
FULL TEXT  

Lifestyle Medicine Strategies for Risk Factor Reduction, Prevention, and Treatment of Coronary Heart Disease: Part II
Rippe et al.
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2007;1:79-90.
ABSTRACT  

The medical complications of obesity
Malnick and Knobler
QJM 2006;99:565-579.
FULL TEXT  

Dietary Approaches to Prevent and Treat Hypertension: A Scientific Statement From the American Heart Association
Appel et al.
Hypertension 2006;47:296-308.
ABSTRACT | FULL TEXT  

What is the relationship between risk factor reduction and degree of weight loss?
Van Gaal et al.
Eur Heart J Suppl 2005;7:L21-L26.
ABSTRACT | FULL TEXT  

Pounds Off With Empowerment (POWER): A Clinical Trial of Weight Management Strategies for Black and White Adults With Diabetes Who Live in Medically Underserved Rural Communities
Mayer-Davis et al.
AJPH 2004;94:1736-1742.
ABSTRACT | FULL TEXT  

Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Neter et al.
Hypertension 2003;42:878-884.
ABSTRACT | FULL TEXT  

The Diabetes Prevention Program (DPP): Description of lifestyle intervention
The Diabetes Prevention Program Research Group
Diabetes Care 2002;25:2165-2171.
ABSTRACT | FULL TEXT  

Anesthetic Considerations for Bariatric Surgery
Ogunnaike et al.
Anesth. Analg. 2002;95:1793-1805.
FULL TEXT  

Promoting Healthy Lifestyles: Alternative Models' Effects (PHLAME)
Moe et al.
Health Educ Res 2002;17:586-596.
ABSTRACT | FULL TEXT  

An Oat-Containing Hypocaloric Diet Reduces Systolic Blood Pressure and Improves Lipid Profile beyond Effects of Weight Loss in Men and Women
Saltzman et al.
J. Nutr. 2001;131:1465-1470.
ABSTRACT | FULL TEXT  

Epidemiologic Data on the Relationships of Caloric Intake, Energy Balance, and Weight Gain Over the Life Span With Longevity and Morbidity
Lee et al.
J Gerontol A Biol Sci Med Sci 2001;56:7-19.
ABSTRACT | FULL TEXT  

Long-Term Weight Loss and Changes in Blood Pressure: Results of the Trials of Hypertension Prevention, Phase II
Stevens et al.
ANN INTERN MED 2001;134:1-11.
ABSTRACT | FULL TEXT  

Knowledge, Attitudes, and Practices on Hypertension in a Country in Epidemiological Transition
Aubert et al.
Hypertension 1998;31:1136-1145.
ABSTRACT | FULL TEXT  

Lisinopril Versus Hydrochlorothiazide in Obese Hypertensive Patients : A Multicenter Placebo-Controlled Trial
Reisin et al.
Hypertension 1997;30:140-145.
ABSTRACT | FULL TEXT  

Effects of Weight Loss and Sodium Reduction Intervention on Blood Pressure and Hypertension Incidence in Overweight People With High-Normal Blood Pressure: The Trials of Hypertension Prevention, Phase II
The Trials of Hypertension Prevention Collaborativ
Arch Intern Med 1997;157:657-667.
ABSTRACT  

Treatment of Mild Hypertension: The More Things Change...
Black
JAMA 1993;270:757-759.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.